Escherichia coli O157:H7 infection in Dutch belted and New Zealand white rabbits

Comparative Medicine

Volumn 60, Issue 1, 2010, Pages 31-37

  Panda, Aruna ^a   Tatarov, Ivan ^a   Melton Celsa, Angela R ^c   Kolappaswamy, Krishnan ^a   Kriel, Edwin H ^a   Petkov, Daniel ^a   Coksaygan, Turhan ^a   Livio, Sofie ^b   McLeod, Charles G ^a   Nataro, James P ^b   O'Brien, Alison D ^c   DeTolla, Louis J ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b University of Maryland School of Medicine Center for Vaccine Development   (United States)

^c UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; BREED; BREED DIFFERENCE; CLINICAL FEATURE; CONTROLLED STUDY; ESCHERICHIA COLI; EXPERIMENTAL INFECTION; INFECTION SENSITIVITY; INTESTINE INJURY; KIDNEY INJURY; MALE; NONHUMAN; PATHOLOGY; RABBIT;

ANIMALS; BASE SEQUENCE; DNA PRIMERS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; MALE; POLYMERASE CHAIN REACTION; RABBITS; SPECIES SPECIFICITY;

EID: 77749267471     PISSN: 15320820     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Barrett TJ, Potter ME, Wachsmuth KI. 1989. Bacterial endotoxin both enhances and inhibits the toxicity of shiga-like toxin II in rabbits and mice. Infect Immun 57:3434-3437.
2. Brando RJF, Miliwebsky E, Bentancor L, Deza N, Baschkier A, Ramos MV, Fernandez GC, Meiss R, Rivas M, Palermo MS. 2008. Renal damage and death in weaned mice after oral infection with Shiga toxin-2 producing Escherichia coli strains. Clin Exp Immunol 153:297-306.
3. Centers for Disease Control and Prevention and National Institutes of Health. [Internet]. 2007. Biosafety in microbiological and biomedical laboratories (BMBL), 5th ed. [Cited Jan 2007]. Available at http://www.cdc.gov/ OD/ohs/biosfty/bmbl5/bmbl5toc.htm.
4. Donohue-Rolfe A, Kondova I, Oswald S, Hutto D, Tzipori S. 2000. Escherichia coli O157:H7 strains that express shiga toxin (Stx) 2 alone are more neurotropic for gnotobiotic piglets than are isotypes producing only Stx1 or both Stx 1 and 2. J Infect Dis 181:1825-1829.
5. Eaton KA, Firedman DI, Frances GJ, Tyler JS, Young VB, Haeger J, Abu-Ali G, Whittam TS. 2008. Pathogenesis of renal disease due enterohemorrhagic Escherichiia coli in germ-free mice. Infect Immun 76:3054-3063.
6. Fode-Vaughan KA, Maki JS, Benson JA, Collins MLA. 2003. Direct PCR detection of Escherichia coli O157:H7. Lett Appl Microbiol 37:239-243.
7. Fraser ME, Chernaia MM, Kozlov YV, James MN. 1994. Crystal structure of the holotoxin from Shigella dysenteriae at 2.5 A° resolution. Nat Struct Biol 1:59-64.
8. Friedrich AW, Bielaszewska M, Zhang WL, Pulz M, Kuczius T, Ammon A, Karch H. 2002.Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J Infect Dis 185: 74-84.
9. García A, Bosques CJ, Wishnok JS, Feng Y, Karalius BJ, Butterton JR, Schauer DB, Rogers AB, Fox JG. 2006. Renal injury is a consistent finding in Dutch belted rabbits experimentally infected with enterohemorrhagic Escherichia coli. J Infect Dis 193:1125-1134.
10. Garcia A, Marini RP, Catalfamo JL, Knox KA, Schauer DB, Rogers AB, Fox JG. 2008. Intravenous shiga toxin 2 promotes enteritis and renal injury characterized by polymorphonuclear leukocyte infiltration and thrombosis in Dutch belted rabbits. Microbes Infect 10:650-656.
11. Garcia A, Marini RP, Feng Y, Vitsky A, Knox KA, Taylor NS, Schauer DB, Fox JG. 2002. A naturally occurring rabbit model of enterohemorrhagic Escherichia coli-induced disease. J Infect Dis 186:1682-1686.
12. Griffin PM, Olmstead LC, Petras RE. 1990. Escherichia coli O157: H7-associated colitis: a clinical and histological study of 11 cases. Gastroenterology 99:142-149.
13. Griffin PM, Ostroff SM, Tauxe RV, Greene KD, Wells JG, Lewis JH, Blake PA. 1988. Illness associated with Escherichia coli O157:H7 infections: a broad clinical spectrum. Ann Intern Med 109:705-712.
14. Hughes AK, Stricklett PK, Schmid D, Kohan DE. 2000. Cytotoxic effect of Shiga toxin-1 on human glomerular epithelial cells. Kidney Int 57:2350-2359.
15. Institute for Laboratory Animal Research. 1996. Guide for the care and use of laboratory animals. Washington (DC): National Academies Press.
16. Kaper JB, Gansheroff LJ, Wachtel MR, O'Brien AD. 1998. Intimin-mediated adherence of Shiga toxin-producing Escherichia coli and attaching-and-effacing pathogens, p 148-156. In: Kaper JB, O'Brien AD, editors.Escherichia coli O157:H7 and other shiga toxin-producing E. coli strains. Washington (DC): ASM Press.
17. Keepers TR, Psotka MA, Gross LK, Obrig TG. 2006. A murine model of HUS: shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease. J Am Soc Nephrol 17:3404-3414.
18. Kurioka T, Yunou Y, Kita E. 1998. Enhancement of susceptibility to shiga toxin-producing Escherichia coli O157:H7 by protein calorie malnutrition in mice. Infect Immun 66:1726-1734.
19. Levine MM. 1987. Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent. J Infect Dis 155:377-389.
20. Li Z, Bell C, Buret A, Robins-Browne R, Stiel D, O'Loughlin E. 1993. The effect of enterohemorrhagic Escherichia coli O157:H7 on intestinal structure and solute transport in rabbits. Gastroenterology 104:467-474.
21. Mani N, Dupuy B. 2001. Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor. Proc Natl Acad Sci USA 98:5844-5849.
22. Morel-Maroger L, Kanfer A, Solez K, Sraer JD, Richet G. 1979. Prognostic importance of vascular lesions in acute renal failure with microangiopathic hemolytic uremia (hemolytic-uremic syndrome): clinicopathologic study in 20 adults. Kidney Int 15:548-558.
23. Nataro JP, Kaper JB. 1998. Diarrheagenic Escherichia coli. Clin Microbiol Rev 11: 142-201.
24. O'Brien AD, Lively TA, Chen ME, Rothman SW, Formal SB. 1983. Escherichia coli O157:H7 strains associated with hemorrhagic colitis in the United States produce a Shigella dysenteriae 1 (Shiga)-like cytotoxin. Lancet 321:702.
25. Ochoa TJ, Cleary TG. 2003. Epidemiology and spectrum of disease of Escherichia coli O157:H7. Curr Opin Infect Dis 16:259-263.
26. O'Loughlin EV, Robins-Browne RM. 2001. Effects of Shiga- toxin and Shiga-like toxins on eukaryotic cells. Microbes Infect 3:493-507.
27. Olsvik O, Rimstad E, Hornes E, Strockbine N, Wasteson Y, Lund A, Wachsmuth K. 1991. A nested PCR followed by magnetic separation of amplified fragments for detection of Escherichia coli Shiga-like toxins genes. Mol Cell Probes 5:429-435.
28. Pai CH, Kelly JK, Meyers GL. 1986. Experimental infection of infant rabbits with verotoxin-producing Escherichia coli. Infect Immun 51:16-23.
29. Paton JC, Paton AW. 1998. Pathogenesis and diagnosis of Shiga-toxin producing Escherichia coli infections. Clin Microbiol Rev 11:450-479.
30. Proulx F, Seidman EG, Karpman D. 2001. Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome. Pediatr Res 50:163-171.
31. Rangel JM, Sparling PH, Crowe C, Griffin PM, Swerdlow DL. 2005. Epidemiology of Escherichia coli O157:H7 outbreaks, United States, 1982-2002. Emerg Infect Dis 11:603-609.
32. Richardson SE, Rotman TA, Jay V, Smith CR, Becker LE, Petric M, Olivieri NF, Karmali MA. 1992. Experimental verocytotoxemia in rabbits. Infect Immun 60:4154-4167.
33. Riley LW, Remis RS, Helgerson SD, McGee HB, Wells JG, Davis BR, Hebert RJ, Olcott RS, Johnson LM, Hargrett NT, Blake PA, Cohen ML. 1983. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 308:681-685.
34. 2, eae, and tir in enterohemorrhagic Escherichia coli-induced diarrhea and intestinal inflammation in infant rabbits. Infect Immun 71:7129-7139.
35. Sauter KA, Melton-Celsa AR, Larkin K, Troxell ML, O'Brien AD, Magun BE. 2008. Mouse model of hemolytic uremic syndrome caused by endotoxin-free Shiga toxin 2 (Stx2) and protection from lethal outcome by anti-Stx2 antibody. Infect Immun 76:4469-4478.
36. Sherman P, Soni R, Karmali M. 1988. Attaching and effacing adherence of Vero cytotoxin-producing Escherichia coli to rabbit intestinal epithelium in vivo. Infect Immun 56:756-761.
37. Simon M, Cleary TG, Hernandez JD, Abboud HE. 1998. Shiga toxin 1 elicits diverse biologic responses in mesengial cells. Kidney Int 54:1117-1127.
38. Smith MJ, Carvalho HM, Melton-Celsa AR, O' Brien AD. 2006. The 13C4 monoclonal antibody that neutralizes Shiga toxin type 1 (Stx) recognizes three regions on the Stx1 B subunit and prevents Stx1 from binding to its eukaryotic receptor globotriaosylceramide. Infect Immun 74:6992-6998.
39. Smith MJ, Teel LD, Carvalho HM, Melton-Celsa AR, O'Brien AD. 2006. Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins type 1 and 2. Vaccine 24:4122-4129.
40. Tarr PI, Gordon CA, Chandler WL. 2005. Shiga-toxin producing Escherichia coli and hemolytic uremic syndrome. Lancet 365:1073-1086.
41. Wadolkowski EA, Burris JA, O'Brien AD. 1990. Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7. Infect Immun 58:2438-2445.
42. Wen SX, Teel LD, Judge NA, O'Brien AD. 2006. Genetic toxoids of Shiga toxin types 1 and 2 protect mice against homologous but not heterologous toxin challenge. Vaccine 24:1142-1148.
43. Woods JB, Schmitt CK, Darnell SC, Meysick KC, O'Brien AD. 2002. Ferrets as a model system for renal disease secondary to intestinal infection with Escherichia coli O157:H7 and other Shiga toxin-producing E. coli. J Infect Dis 185:550-554.